Research output per year
Research output per year
Fingerprint
Dive into the research topics where Luca Morello is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Research output
- 2 Article
-
A First-in-human Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor, in Patients With Relapsed/Refractory Hematologic Malignancies: Results From the European Study: Clinical Lymphoma, Myeloma and Leukemia
Carlo-Stella, C., Delarue, R., Scarfo, L., Barde, P. J., Nair, A., Locatelli, S. L., Morello, L., Magagnoli, M., Vakkalanka, S., Viswanadha, S. & Ferreri, A. J. M., 2020, In: Clin. Lymphoma Myeloma Leukemia. 20, 2, p. 78-86 9 p.Research output: Contribution to journal › Article › peer-review
-
Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study
Visco, C., Di Rocco, A., Evangelista, A., Quaglia, F. M., Tisi, M. C., Morello, L., Zilioli, V. R., Rusconi, C., Hohaus, S., Sciarra, R., Re, A., Tecchio, C., Chiappella, A., Marin-Niebla, A., McCulloch, R., Gini, G., Perrone, T., Nassi, L., Pennese, E., Stefani, P. M. & 13 others, , 2020, In: Leukemia.Research output: Contribution to journal › Article › peer-review